Life sciences · Preprint
arXiv · October 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Machine learning (ML) models used in clinical workflows often perform systematically differently across patient groups, raising concerns about equity and patient safety. Traditional subgroup analyses can expose such disparities only when rich metadata (e.g., patient demographics) is available and captures the sources of performance variation, conditions rarely met in practice. Algorithmic subgroup discovery methods offer a solution by identifying coherent groups from learned feature representations, but because true underlying stratifications are unknown, these methods are hard to evaluate. As a result, subgroup discovery has not been systematically applied or assessed for performance monitoring. Our main objective is to evaluate algorithmic subgroup discovery for performance monitoring, assessing the discovered subgroups' performance gaps and semantic coherence. Investigating cardiomegaly classification in a dataset of 223,228 chest X-rays, we showed that the discovered subgroups exhibited larger performance gaps (accuracies of 0.61-0.90) than traditional metadata-based analysis (0.80-0.94) and were frequently interpretable using patient, acquisition, and model metadata. As a proof of concept, we also showed that annotations from learned subgroups can be used to mitigate the biases they expose. We conclude that subgroup discovery is a practical and effective tool to enhance the performance validation and monitoring of ML systems in healthcare.